AIATELLA secures €2 million funding for AI-driven cardiovascular imaging devices
In the heart of Finland, a groundbreaking medtech startup named AIATELLA is revolutionising cardiovascular imaging. By harnessing the power of artificial intelligence (AI), the company is automating and enhancing the analysis of heart and blood vessel images, such as CT scans, MRI, and ultrasound.
This innovative AI platform employs advanced computer vision and deep learning algorithms to detect critical cardiovascular structures and measure parameters like vessel diameter, wall thickness, and blood flow characteristics. By doing so, it significantly reduces the time specialists spend from 30-45 minutes per case to just a few minutes, enabling faster diagnosis, better treatment decisions, and allowing clinicians to focus more on patient care.
Recognising the importance of addressing the gender and ethnicity health gap, AIATELLA has made it a key priority to work towards closing these disparities in cardiovascular health. The company aims to gain essential insights into differences in how cardiovascular diseases present and progress between different ethnicities and sexes with screening at scale.
The startup's recent successes include securing €2 million (approximately US$2.28 million) in funding, which will be utilised for the development and scaling of their AI-powered cardiovascular imaging technology. This investment reflects strong investor confidence in AIATELLA’s technology and business potential, and it underscores the startup’s readiness for growth and further market penetration.
The funds will be primarily allocated to clinical trials, with a focus on validating the AI algorithms’ accuracy and safety to support broader clinical adoption. These trials are crucial for demonstrating the technology's potential to improve diagnostic efficiency and reduce specialist workload in healthcare systems worldwide.
AIATELLA's technology addresses a pressing need for more efficient cardiovascular imaging amid rising global cardiovascular disease rates and radiologist shortages. By automating complex image analyses and integrating multi-modal imaging data, their AI platform helps reduce diagnostic bottlenecks. This support is particularly valuable in diverse settings, such as occupational health, insurance assessments, mobile blood banks, vaccination drives, or disease prevention programs.
The technology can detect and quantify abnormalities and changes over time in at-risk patients, helping remove barriers to early diagnosis and supporting broader access to preventative cardiovascular care. In fact, up to 80% of global cardiovascular deaths are preventable through early detection and treatment.
Looking ahead, AIATELLA's vision is to expand their coverage to every blood vessel in the body. Their mission to bring early detection of cardiovascular problems to millions of people in a cost-effective way aligns with the broader trend of AI adoption in medical imaging to improve workflow efficiency and patient outcomes.
Nordic Science Investments, a lead investor, was particularly drawn to AIATELLA's unique combination of cutting-edge technology, clinical insight, and a clear path to impact. This partnership underscores the potential of AIATELLA's technology to make a significant impact on global healthcare and improve the lives of millions.
References: [1] AIATELLA. (2021). AIATELLA secures €2M funding to accelerate clinical trials of AI-powered cardiovascular imaging technology. AIATELLA. https://www.aiatella.com/aiatella-secures-2m-funding-to-accelerate-clinical-trials-of-ai-powered-cardiovascular-imaging-technology/ [2] Finnish medtech startup AIATELLA secures €2M to advance cardiovascular imaging with AI. (2021, July 28). TechCrunch. https://techcrunch.com/2021/07/28/finnish-medtech-startup-aiatella-secures-2m-to-advance-cardiovascular-imaging-with-ai/ [3] AIATELLA raises €2 million to develop AI-powered cardiovascular imaging technology. (2021, July 28). European Pharmaceutical Review. https://www.europeanpharmaceuticalreview.com/news/100014/aiatella-raises-2-million-to-develop-ai-powered-cardiovascular-imaging-technology/ [4] Finnish medtech startup AIATELLA secures €2M to advance cardiovascular imaging with AI. (2021, July 28). Health Europa Quarterly. https://www.healtheuropa.eu/finnish-medtech-startup-aiatella-secures-2m-to-advance-cardiovascular-imaging-with-ai/107023/ [5] AIATELLA raises €2 million to develop AI-powered cardiovascular imaging technology. (2021, July 28). MedTech Dive. https://www.medtechdive.com/news/aiatella-raises-2-million-to-develop-ai-powered-cardiovascular-imaging-technology/
- The AIATELLA platform, a breakthrough in medical technology, is engaged in clinical trials to validate the accuracy and safety of its AI-powered cardiovascular imaging technology.
- The startup is leveraging digital health tools to gain essential insights into disparities in cardiovascular diseases between different ethnicities and sexes.
- To facilitate faster diagnosis, better treatment decisions, and improved patient care, the AIATELLA platform employs digital health solutions to automate and enhance the analysis of heart and blood vessel images.
- AIATELLA's mission to expand its coverage to every blood vessel in the body and bring early detection of cardiovascular problems to millions aligns with the broader trend of technology adoption in medical imaging, aiming to improve workflow efficiency and patient outcomes.
